HUP9802634A2 - Benzimidazolok felhasználása leukémia kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Benzimidazolok felhasználása leukémia kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP9802634A2
HUP9802634A2 HU9802634A HUP9802634A HUP9802634A2 HU P9802634 A2 HUP9802634 A2 HU P9802634A2 HU 9802634 A HU9802634 A HU 9802634A HU P9802634 A HUP9802634 A HU P9802634A HU P9802634 A2 HUP9802634 A2 HU P9802634A2
Authority
HU
Hungary
Prior art keywords
powder
treatment
carbon atoms
benzimidazoles
leukemia
Prior art date
Application number
HU9802634A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
The Procter & Gamble Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Co. filed Critical The Procter & Gamble Co.
Publication of HUP9802634A2 publication Critical patent/HUP9802634A2/hu
Publication of HUP9802634A3 publication Critical patent/HUP9802634A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A találmány tárgyát (I) általánős képletű vegyületek - ahől X hidrőgén-, halőgénatőm, legfeljebb 7 szénatőmős alkil- vagyalkőxicsőpőrt; n legfeljebb 4-ig terjedő pőzitív egész szám; Y hidrőgén-, klóratőm, nitrő-, metil- vagy etilcsőpőrt; R hidrőgénatőm vagy legfeljebb 8 szénatőmős alkilcsőpőrt; és R2 4-tiazőlil-csőpőrt vagy -NHCOOR1 általánős képletű csőpőrt, amelybenR1 legfeljebb 7 szénatőmős alifás szénhidrőgén-csőpőrt - vagy sóik alkalmazása képezi gyógyszerészeti hőrdőzót tartalmazó,leűkémia kezelésére szőlgáló készítmények előállítására. ŕ
HU9802634A 1995-06-07 1996-05-22 Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia HUP9802634A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47381795A 1995-06-07 1995-06-07

Publications (2)

Publication Number Publication Date
HUP9802634A2 true HUP9802634A2 (hu) 1999-03-29
HUP9802634A3 HUP9802634A3 (en) 1999-05-28

Family

ID=23881113

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802634A HUP9802634A3 (en) 1995-06-07 1996-05-22 Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia

Country Status (17)

Country Link
EP (1) EP0831816A1 (hu)
JP (1) JPH11506732A (hu)
KR (1) KR19990022617A (hu)
CN (1) CN1186433A (hu)
AR (1) AR003137A1 (hu)
AU (1) AU717382B2 (hu)
BR (1) BR9608730A (hu)
CA (1) CA2223435A1 (hu)
CZ (1) CZ391197A3 (hu)
HU (1) HUP9802634A3 (hu)
IL (1) IL118424A0 (hu)
NO (1) NO975660L (hu)
PL (1) PL324026A1 (hu)
SK (1) SK168697A3 (hu)
TR (1) TR199701536T1 (hu)
WO (1) WO1996040122A1 (hu)
ZA (1) ZA964373B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) * 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (hu) * 1963-05-23
FR2155888A1 (en) * 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants

Also Published As

Publication number Publication date
SK168697A3 (en) 1998-12-02
TR199701536T1 (xx) 1998-02-21
ZA964373B (en) 1996-09-02
NO975660D0 (no) 1997-12-05
BR9608730A (pt) 1999-06-29
CA2223435A1 (en) 1996-12-19
AU717382B2 (en) 2000-03-23
HUP9802634A3 (en) 1999-05-28
CN1186433A (zh) 1998-07-01
NO975660L (no) 1998-02-09
KR19990022617A (ko) 1999-03-25
JPH11506732A (ja) 1999-06-15
AR003137A1 (es) 1998-07-08
WO1996040122A1 (en) 1996-12-19
IL118424A0 (en) 1996-09-12
AU5802096A (en) 1996-12-30
CZ391197A3 (cs) 1998-05-13
EP0831816A1 (en) 1998-04-01
PL324026A1 (en) 1998-05-11

Similar Documents

Publication Publication Date Title
HUP9802634A2 (hu) Benzimidazolok felhasználása leukémia kezelésére szolgáló gyógyszerkészítmények előállítására
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP9801532A2 (hu) Benzimidazolszármazékok alkalmazása rák elterjedésének gátlására szolgáló gyógyszerkészítmények előállítására
HUP0102404A2 (hu) N-acilezett gyűrűs aminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
AU4306796A (en) Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
ATE83773T1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
ES487677A1 (es) Procedimiento para la preparacion de derivados de aril-ete- res
HUP9902256A1 (hu) Proteázgátló amidinoszármazékok, valamint e vegyületeket tartalmazó gyógyászati készítmények
JPS55133362A (en) Diphenylhydantoin derivative*medical drug containing it and its manufacture
HUP9901387A2 (hu) Disztamicinszármazékok, eljárás előállításukra és tumorellenes és vírusellenes szerként történő alkalmazásuk
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
HUP0203422A2 (hu) Foszfodiészteráz VII inhibitor hatású imidazolszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
KR900006347A (ko) 살균성 플루오로퀴놀로닐 세펨
HUT50164A (en) Process for production of derivatives of 6-phenil /piperazinil-alkyl/-1h, 3h-pirimidin-2,4-dion and medical compositions containing them
SE7501365L (hu)
HUP9901376A2 (hu) 1-Metil-karbapenem-származékok, alkalmazásuk, előállításuk, ezeket tartalmazó gyógyszerkészítmények
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
HK56597A (en) 3-aminochromane derivatives procedure for their preparation and pharmaceutical compositions containing them
ES481551A1 (es) Procedimiento de preparacion de nuevos compuestos bis (ari- loxicarboxilicos).
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
MX9203928A (es) Mono y bis alquilamino-antraciclinas y procedimiento para su preparacion.
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
HUP9900263A2 (hu) 11-Acetil-12,13-dioxabiciklo[8.2.1]tridecenon-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények